Pediatric Vaccines Market Size, Share, Growth, and Industry Growth by Type (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, and Others) By End Users (Newborn, Infant, Child, and Dolescent) Regional Forecast To 2031

Updated On: 08 April 2024

PEDIATRIC VACCINES MARKET REPORT OVERVIEW

• 
• Request Free Sample PDF learn more about this report

global pediatric vaccines market size was USD 32340 million in 2022 and market is projected to touch USD 53260.04 Million By 2031, exhibiting a CAGR of 5.7% during the forecast period.

The global COVID-19 pandemic has been unprecedented and staggering, with pediatric vaccines experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.

Pediatric vaccines are administered to children and infants. It is a process and an integral part of immunization. Further, the vaccination is made to become resistant to a variety of disease-causing agents such as viruses and bacteria.

Rising prevalence of numerous diseases such as influenza, tetanus, pertussis, and diphtheria is estimated to surge market growth. Growing number of infectious and non-infectious diseases among children is anticipated to fuel market growth. Increasing government and private sector funding for developing novel vaccines. Also, growing awareness among people about immunization is estimated to fuel market growth. Rise in research and development (R&D) activities by major market players are predicted to fuel market expansion in the forthcoming years. Increasing number of approvals for vaccines and growing number of laborites globally. These factors are predicted to witness a lucrative opportunity for the growth of the market. Entry of new vaccines and high demand for the vaccines is estimated to expand market growth. However, stringent guidelines and high cost of the vaccines are expected to restrict pediatric vaccines market expansion.

COVID-19 Impact: Outbreak of COVID-19 Negatively Impacted Market Growth

COVID-19 pandemic had a negative impact on the market. Spreading of coronavirus and increasing number of cases encouraged manufacturing of vaccines. An outbreak of COVID-19 accelerated the awareness about vaccines. Majority of the people adapted vaccines to fight against the virus and increase immunity. Adoption of vaccines helps to decrease the number of COVID-19 cases.

On the contrary, lockdown restrictions and limited access to clinics slow down the patient flow. Also, temporarily closure of non-essential care and restricted hospital access decline product adoption.

LATEST TRENDS

"Prevalence of Numerous Diseases to Fuel Market Expansion"

Increasing prevalence of various diseases such as influenza, tetanus, pertussis, and diphtheria is estimated to surge market growth. Vaccination helps to fight such infections and create immunity. Our body needs a robust immune system to fight against viruses and bacteria. High demand for permanent protection is predicted to surge market growth. Growing awareness about children's and adult's healthcare is projected to drive market progress. Such diseases are spread by air, direct contact, and contaminated water or food. Growing concern about fighting against such diseases and reducing the chances of infections are estimated to fuel market growth in the upcoming years.

PEDIATRIC VACCINES MARKET SEGMENTATION

• 
• Request Free Sample PDF learn more about this report

• By Type

Based on type, the market is divided diphtheria, influenza, hepatitis, pneumococcal diseases, meningococcal diseases, and others.

Diphtheria is expected to be the leading part of the segmentation type.

• By End User

Based on the end user, the market is divided into newborn, infant, child, and dolescent.

Newborn is expected to be the leading part of end user segmentation.

DRIVING FACTORS

"Initiatives by Government Globally to Surge Market Progress"

Increasing initiatives by government to develop vaccines are estimated to surge market growth. Growing number of funding from government and non-government to develop novel vaccines. Increase in research and development (R&D) activities and growing lab activities is anticipated to surge market expansion. Multiple companies are testing and introducing new vaccines for children and adults. Wide commercial availability of vaccines and pediatric population is expected to expand market expansion. Even support from World Health Origination (WHO) to develop novel vaccines and increasing demand to improve global health is predicted to surge market growth. Growing adoption of advanced technology in healthcare sector and rising research by professionals to develop cost-effective vaccines which are anticipated to fuel market growth. Increasing disposable income of population and growing capacity of people to afford vaccines is estimated to expand market growth. Further, government regulations to provide vaccines and arranging camps to create awareness about vaccination process. Such factors are estimated to propel pediatric vaccines market progress in the upcoming years.

"Focus on Improving Healthcare Sector to Magnify Pediatric Vaccines Demand"

Growing focus on improving healthcare sector is predicted to surge market growth. High demand for the vaccines and support from professionals is anticipated to propel market growth. Increasing focus on improving primary healthcare infrastructure is estimated to expand market growth. Adoption of vaccines played an instrumental role in minimizing the spread of numerous diseases. A high need to improve the effectiveness of existing vaccines is anticipated to fuel market growth. Further, several integration programs for children and recent awareness about antibodies are predicted to surge market growth. Additionally, rising economic growth and collaboration of national manufacturers are anticipated to accelerate market growth in the upcoming years. Vaccines help to save millions of lives, and awareness about immunization is estimated to accelerate pediatric vaccines market growth in the forthcoming years.

"Importance of Vaccines among Children to Incite Market Progress"

Growing importance of vaccines among children is anticipated to surge market growth. Vaccination protects children from deadly diseases such as tetanus, diphtheria, and polio. High demand for novel vaccines to save children and increase immunity. High order to reduce spreading of dangerous conditions and need to control the spread of child to child. These factors are estimated to fuel market growth. Vaccines help to build antibodies and act as a germ-fighting machine. They are safe for children and newborns. Growing number of parents are aware of the benefits of vaccines. These factors are responsible for accelerating pediatric vaccines market growth during the forecast period.

RESTRAINING FACTORS

"High Cost and Stringent Guidelines to Hamper Market Growth"

Stringent guidelines and the high cost of the vaccines are expected to restrict market expansion. Further presence of biosimilar at low rates is anticipated to obstruct market growth in the coming years.

PEDIATRIC VACCINES MARKET REGIONAL INSIGHTS

• 
• Request Free Sample PDF learn more about this report

"Growing Research and Development Activities to Drive Market Share in North America "

North America is predicted to expand pediatric vaccines market share due to growing research and development (R&D) activities. Advancement in rotavirus vaccines in the region is anticipated to surge market growth. Increasing government and private sector funding for developing novel vaccines. Also, growing awareness among people about immunization is estimated to fuel market growth. Rise in number of approvals and presence of advance technology. Along with an increase in the number of laboratories and awareness about vaccination in the region. These factors are estimated to surge market growth in the upcoming years. 

KEY INDUSTRY PLAYERS

"Leading Players Adopt New Strategies to Stay Competitive"

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• GlaxoSmithKline (U.K.)
• Merck (U.S.)
• Pfizer (U.S.)
• Sanofi (France) 
• AstraZeneca (U.K.)
• Novartis (Switzerland) 
• Takeda Pharmaceutical (Japan)
• Bavarian Nordic (Denmark)
• Baxter (U.S.)
• LG Life Sciences (South Korea) 
• Lupin (India)
• S K Chemicals (South Korea)
• Mitsubishi Tanabe Pharma (Japan)
• Janssen (U.S.)
• Shenzhen Kangtai Biological Products (China)
• Sinovac Biotech (China)
• Bharat Biotech (India)
• Crucell (Netherlands)
• Dynavax (U.S.)
• Serum Institute of India (India)

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.